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Plasmodium infection during gestation may lead to severe clinical manifestations including
abortion, stillbirth, intrauterine growth retardation, and low birth weight. Mechanisms
underlying such poor pregnancy outcomes are still unclear. In the animal model of severe
placental malaria (PM), in utero fetal death frequently occurs and mothers often succumb to
infection before or immediately after delivery. Plasmodium berghei -infected erythrocytes
(IEs) continuously accumulate in the placenta, where they are then phagocytosed by fetal-
derived placental cells, namely trophoblasts. Inside the phagosomes, disruption of IEs
leads to the release of non-hemoglobin bound heme, which is subsequently catabolized by
heme oxygenase-1 into carbon monoxide, biliverdin, and labile iron. Fine-tuned regulatory
mechanisms operate to maintain iron homeostasis, preventing the deleterious effect of
iron-induced oxidative stress. Our preliminary results demonstrate that iron overload in
trophoblasts of P. berghei -infected placenta is associated with fetal death. Placentas
which supported normally developing embryos showed no iron accumulation within the
trophoblasts. Placentas from dead fetuses showed massive iron accumulation, which
was associated with parasitic burden. Here we present preliminary data suggesting that
disruption of iron homeostasis in trophoblasts during the course of PM is a consequence of
heme accumulation after intense IE engulfment.We propose that iron overload in placenta
is a pathogenic component of PM, contributing to fetal death. The mechanism through
which it operates still needs to be elucidated.
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INTRODUCTION
Malaria is an infectious disease that affects millions of individuals
every year and remains one of the major causes of morbid-
ity and mortality worldwide (WHO | World Malaria Report,
2013). The disease is transmitted by Anopheles mosquito car-
rying Plasmodium parasites. Once injected in the blood stream,
Plasmodium replicate and mature in the liver (liver stage) before
infecting erythrocytes (blood stage; Schoﬁeld and Grau, 2005).
The blood stage of infection is known to be associated to clini-
cal manifestations of the disease (Mackintosh et al., 2004; Haldar
et al., 2007). Plasmodium parasites proliferate inside red blood
cells; within these erythrocytes circulate freely in the blood-
stream and are under risk of removal by the spleen – the organ
responsible for eliminating old and modiﬁed erythrocytes (Janicik
et al., 1978). To avoid this host defense mechanism, intracellu-
lar parasites export to the erythrocyte membrane molecules that
interact with receptors on the vascular endothelium (Krücken
et al., 2005), enabling adherence/sequestration of the infected ery-
throcyte (IE) in the microvasculature of speciﬁc organs such as
lung, heart, and brain (Pongponratn et al., 1991). IE sequestra-
tion is considered one of the major factors in triggering organ
inﬂammation, leading to severe clinical forms of disease such
as cerebral malaria (Carter et al., 2005; Ponsford et al., 2012).
It has recently been shown that proliferation and maturation
of mutant parasites lacking ability to adhere to host endothe-
lium is reduced in mice when compared to wild-type parasites
(Fonager et al., 2012) strengthening the hypothesis that adher-
ence impacts Plasmodium proliferation during the blood stage of
infection.
In 2007 over 125 million women living in areas with Plasmod-
ium falciparum and or P. vivax transmission became pregnant
and at risk of developing malaria (Dellicour et al., 2010). Preg-
nant women bitten by infected mosquitoes can develop placental
malaria (PM; known also as pregnancymalaria) – a disease charac-
terized by adverse pregnancy outcomes such as abortion, stillbirth,
premature delivery and low birth weight babies, which in turn
increases infant morbidity. These clinical features can be reca-
pitulated in a BALB/c mouse model of infection at mid-stage
pregnancy (Neres et al., 2008) and are associated to accumulation
of Plasmodium IEs in the placenta (Fried and Duffy, 1996).
The placenta is a favored niche for IE sequestration and there
are two different explanations for this phenomenon. Placental
cells, speciﬁcally trophoblasts which are epithelial cells of fetal
origin, express chondroitin sulfate A (CSA) – a sulfated gly-
cosaminoglycan – on their surface (Duffy and Fried, 1999). This
offers a binding site for VAR2CSA, a protein encoded for the
human malaria parasite P. falciparum, exposed on the membrane
of IEs (Salanti et al., 2003, 2004; Duffy et al., 2006; Srivastava
et al., 2010). Physical CSA–VAR2CSA interaction allows the adhe-
sion of IEs to placental tissue. Microcirculatory dynamics of the
placenta is another important factor in IE sequestration. We
recently described that the speed of maternal blood circulation
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in the mouse placenta is heterogeneous: there are areas of high,
moderate, and low blood ﬂow (de Moraes et al., 2013). In pla-
centas infected with P. berghei – a rodent parasite that lacks the
VAR2CSA molecule (Jemmely et al., 2010) – accumulation of
IEs is increased in low maternal blood ﬂow regions (de Moraes
et al., 2013). This highlights the relevance of placental tissue
conﬁguration in promoting sequestration of Plasmodium IEs.
We hypothesized that IE sequestration may occur through spe-
ciﬁc interaction of IEs with the trophoblast membrane and is
favored by IE arrest in maternal regions characterized of low blood
ﬂow.
Placental IE sequestration leads to a local inﬂammatory
response characterized by monocyte inﬁltration (Abrams et al.,
2003). Trophoblasts are also capable of phagocytosing IEs (de
Moraes et al., 2013) yeast and bacteria (Amarante-Paffaro et al.,
2004) in an attempt to eliminate invading microbes. Trophoblast
responses to infection may be deleterious to the developing fetus.
Despite many evidences that link PM to placental inﬂamma-
tion, mechanisms underlying poor pregnancy outcomes are still
unclear.
Our preliminary data in a mouse model of PM show an associ-
ation between iron overload in trophoblast of P. berghei-infected
placentas and fetal death. Iron accumulation was observed in 43%
of placentas from dead fetuses and was associated to the dose
of injected IEs. Iron deposits were never detected in placentas
from live embryos. Our preliminary results also show downregu-
lation of mRNA expression of the heme exporter feline leukemia
virus C receptor 1a (FLVCR1a) in infected placentas suggesting
a role for this molecule in dysregulation of iron homeostasis
in PM. Here, we discuss how iron is regulated during preg-
nancy and develop a hypothesis to explain infection-induced iron
overload in trophoblasts. This may help explain the poor preg-




Iron is essential for all living organisms. It is important in a variety
of biological functions involving reduction and oxidation reac-
tions which are crucial for cell survival and proliferation (Crichton
andCharloteaux-Wauters,1987). Iron can exchange electronswith
a number of different substrates, necessitating tight control of the
reactivity of thismetal (Hentze et al., 2004). Control is provided by
cellular and systemic mechanisms that have been evolved to main-
tain iron homeostasis and prevent its participation in the Fenton
chemistry (Fenton, 1894). Disruption of iron homeostasis leads
to production of highly reactive hydroxyl radicals, the cytotoxic
effect of which is associated with tissue iron overload, organ dys-
function and disease severity, recently demonstrated in the case of
severe forms of malaria (Gozzelino et al., 2012).
Dietary iron is absorbed by the duodenum, transported into
the cytosol by the divalent metal transporter-1 (DMT1; Fleming
et al., 1997; Gunshin et al., 1997; Veuthy and Wessling-Resnick,
2014) and then either storedwithinmultimeric subunits of ferritin
(Harrison and Arosio, 1996) or released into the circulation by
the iron exporter ferroportin (Donovan et al., 2000; McKie et al.,
2000). Extracellular iron is bound to transferrin (Tf) and delivered
to cells by interaction with Tf receptors (TfR; Aisen, 1998) where it
ismainly used for heme biosynthesis and erythropoiesis (Andrews,
2000).
During pregnancy, maternal iron absorbance increases sub-
stantially throughout the gestational period [from 0.8 mg/day in
the ﬁrst trimester to 7.5 mg/day in the third trimester (Bothwell,
2000)] to fulﬁll the needs of the developing fetus. Increased iron
absorption is also required for maternal erythropoiesis, to main-
tain hemoglobin (Hb) levels (Bothwell, 2000) and to increase the
iron stores to compensate for blood loss during delivery (Milman,
2006). Studies have shown that 40–70% of iron that is transferred
to the fetus derives from maternal iron stores (Murray and Stein,
1970; Bothwell, 2000), suggesting that fetus canmobilize iron from
this resource; this will be further discussed.
Maternal iron status during pregnancy can be monitored by
biomarkers such as Hb, hematocrit, serum ferritin (SF), serum
soluble TfR (sTfR), and total body iron (TBI). SF concentration is
a well established marker for iron reserves; SF levels ≤30 μg/L are
indicative of low iron reserves and levels ≤12 μg/L are associated
with iron deﬁciency (Milman, 2006). Soluble TfR are detached
receptors from young erythrocytes which in high concentrations
indicate iron deﬁciency at cellular level and may be useful marker
to monitor erythropoiesis (Feelders et al., 1999). Both SF and sTfR
measurements during pregnancy yield reliable information on
maternal iron status; the sTfR-index (sTfR/log SF) is a practi-
cable parameter for patients with depleted iron stores (Punnonen
et al., 1997) and during pregnancy may correct for plasma volume
expansion differences (Cao and O’Brien, 2013).
Another parameter for assessment of iron homeostasis is hep-
cidin, a hormone mainly produced by the liver that controls
iron efﬂux. Hepcidin binds to ferroportin, induces internaliza-
tion and degradation of this molecule, preventing iron export
from the cell (Nemeth et al., 2004). Levels of hepcidin vary
according to the iron concentrations in circulation, and kinet-
ics of this hormone during pregnancy is indicative of the status
of maternal iron stores (Simavli et al., 2014). In a cohort of
healthy Northern European pregnant women, reduced levels of
hepcidin correlated with decreased ferritin and iron concentra-
tions, which occur simultaneously to an increase in sTfR-index
in the third trimester (van Santen et al., 2013). As proposed in
this study, low hepcidin production might reﬂect increased iron
demands of the developing fetus and increase in maternal erythro-
poietic activity during pregnancy, which reduces maternal iron
stores.
The effect of Plasmodium placental infection on maternal
and cord blood iron parameters [hepcidin, iron, ferritin, sTfR,
Tf saturation (TS)] has been considered. In a population from
Gabon, anemic women with PM had a trend for lower levels of
sTfR compared to anemic women without PM suggesting that
parasitemia could affect proliferation of erythroid progenitors
(Van Santen et al., 2011). A slight but not signiﬁcant increase
in ferritin concentrations was also observed in these anemic and
infected pregnant women. Studies conducted in Malawi showed
that infected pregnant women exhibited increased levels of fer-
ritin compared to non-infected and that cord blood ferritin was
correlated with increased maternal parasitemia and lower birth
weight (Abrams et al., 2005). Moreover Hb levels in the fetus
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were not affected by infection suggesting that fetal iron stores are
preserved. Other studies corroborate these observations show-
ing that neither maternal or placental infection had an effect
on Hb levels (Mokuolu et al., 2009; Van Santen et al., 2011) as
well on iron parameters in the cord blood (Van Santen et al.,
2011).
IRON TRANSPORT FROMMOTHER TO FETUS
Both in mouse and human placentas, maternal blood is directly
in contact with trophoblasts. These cells, more speciﬁcally named
cytotrophoblast and syncythiotrophoblasts, are arranged in lay-
ers to form a barrier separating maternal from fetal blood and
allow ﬂux of gas and nutrient to the fetus through different mech-
anisms (Sibley et al., 2010; Figure 1A). Iron is transferred across
the placenta via proteins involved in iron transfer; the detailed
mechanisms regulating trophoblasts uptake of iron from mater-
nal circulation and transfer to the fetus are still unclear. It has
been suggested that iron uptake from maternal serum may occur
primarily via DMT1 (Gruper et al., 2005). DMT1 is a trans-
membrane glycoprotein that transports divalent iron into the
cytoplasm; it is located both in the cell membrane and on late
endosomes (Andrews, 1999). Expression of DMT1 on the api-
cal side of human trophoblasts (facing maternal blood) suggests
DMT1 could play a major role in iron uptake by trophoblasts
also during pregnancy (Gruper et al., 2005). In human term pla-
centas, DMT1 is located predominantly on the maternal side
of syncytiotrophoblasts, more rarely on the fetal side (Li et al.,
2012b). Fetal iron uptake is also mediated by the expression of
TfR on the apical membrane of human placenta (Kroos et al.,
1996; Georgieff et al., 2000; Bastin et al., 2006). This suggests
that the mechanism also operates to ensure iron transport from
maternal circulation to the fetus. TfR is induced during preg-
nancy, in response to iron deﬁciency; it is rapidly transcytosed
to the apical membrane of syncytiotrophoblasts (Gruper et al.,
2005), as demonstrated in rodent (Gambling et al., 2001; Cornock
et al., 2013) and human studies (Li et al., 2012a) of maternal iron
deﬁciency.
Mechanisms of iron transfer from mother to fetus must be well
orchestrated to guarantee adequate iron supply to the developing
embryo. The cross-talk between mother, placenta (trophoblast)
and fetus is not yet well understood but the conductor of the
symphony seems to be the fetus. Studies have shown that fetal
liver iron status directly correlates with TfR expression on pla-
centa and maternal liver, suggesting that the embryo regulates
iron uptake by the mother and at the trophoblast level (Gam-
bling et al., 2009). In a rat model of dietary iron deﬁciency using
FIGURE 1 | Phagocytosis by trophoblasts of infected mouse
placentas at end-stage gestation. (A) placental histology showing
trophoblasts [cytotrophoblasts (CTB) and syncythiotrophoblasts (STB)],
maternal blood space (MBS), endothelial cell (EC), and fetal
capillary (FC) corresponding to the scheme on the upper
right-hand panel. (B,C) placental sections showing engulfed IEs
(arrows in B,C) in trophoblasts. Arrowheads point to IEs. Scale
bar 25 μm.
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two different strains, placental TfR and DMT1 expression were
upregulated, possibly to increase iron transport and supply to
the fetus (Cornock et al., 2013). These studies also showed inter-
strain differences in maternal liver iron contents in controls not
associated to expression of duodenal iron transporters but rather
placental efﬁciency in iron uptake and transfer to the embryo. In
the placenta TfR seems to be modulated by hepcidin; studies on
hepcidin transgenic embryos have shown that expression of TfR
mRNA was signiﬁcantly downregulated in the placentas, suggest-
ing that hepcidin is constitutively produced by the fetal liver and
possibly controlled by fetal iron contents (Gambling et al., 2009)
modulating the iron uptake by trophoblast (Martin et al., 2004).
Underlyingmechanisms are still unclear. Taken together these data
strongly suggest that fetal iron status regulates trophoblast iron
uptake.
Much evidence supports ferroportin 1 (FPN1) as the major
iron export molecule due to its high expression on the basal mem-
brane of the syncytiotrophoblast (Donovan et al., 2000; McKie
et al., 2000; Bastin et al., 2006). However, the observation that
FPN mRNA expression (Gambling et al., 2001; Li et al., 2008) and
protein levels (Gambling et al., 2009; Cornock et al., 2013) on tro-
phoblasts of rat placentas were not altered regardless of maternal
iron status suggests that regulation of iron efﬂux from trophoblast
may not involve the FPN-hepcidin pathway (Gambling et al., 2009;
Cornock et al., 2013). The observation that DMT1 is also localized
on the syncytiotrophoblast basal membrane raises the possibil-
ity that this molecule could be involved in iron efﬂux to the fetal
serum (Georgieff et al., 2000).
IRON DEFICIENCY AND PREGNANCY MALARIA
Inmalaria endemic regions, pregnantwomenwithnutritional iron
deﬁciency who are infected with Plasmodium may be protected
from PM (Kabyemela et al., 2008) but are at risk of developing
severe anemia (Guidotti, 2000) increasing the risk of perinatal
mortality and morbidity (Levy et al., 2005). The apparent con-
tradiction stems from two distinct effects of iron: low levels
may impair fetal development; high concentration could pro-
mote parasite replication, as this metal is strictly required for
the viability of these pathogens (Cabantchik et al., 1996; Ganz,
2009). Iron supplementation trials have shown contradictory
results on pregnancy outcomes during malaria infection (Nacher
et al., 2003; Friedman et al., 2009). Iron and acid folic supple-
mentation has been recommended for all women of child-bearing
age in malaria endemic regions with the aim of overcoming iron
deﬁciency. Safety of this strategy in terms of malaria risk has
not been assessed and remains a concern. Increased malaria risk
has been observed in pregnant women who receive intravenous
iron (Oppenheimer et al., 1986) but oral iron supplementation
increased neither the prevalence nor severity of malaria in Gam-
bian women (Menendez et al., 1994). In contrast, iron deﬁciency
has been associated with decreased susceptibility to P. falciparum
infection in pregnant women in Tanzania (Kabyemela et al., 2008)
but PM appeared to protect Malawian pregnant women from
maternal iron deﬁciency (Senga et al., 2011). Likewise Sudanese
womenwithP. falciparumPMhad low frequency of anemia (Adam
et al., 2012). These epidemiological ﬁndings suggest impairment
of iron metabolism over the course of malaria infection during
pregnancy. On the one hand, decreased iron availability appears
to protect against PM, probably by depriving the parasite of
iron required for expansion during blood stage infection. On
the other hand, PM appears to protect pregnant women from
developing iron deﬁciency, possibly by impairing the mecha-
nism of iron transport in the placenta. Dysregulation of iron
metabolism and distribution in malaria infection may be exacer-
bated during pregnancy, due to increased maternal erythropoiesis
and fetal needs. There is little information on whether alter-
ations in the intricate interaction between maternal and fetal
iron metabolism in PM impose restrictions on fetal growth and
survival. There are so far no hypotheses to explain the inter-
play between iron homoeostasis, pregnancy status, and malaria
infection.
IRON DYSREGULATION IN THE PMMODEL
TROPHOBLAST RESPONSE TO INFECTION
A critical factor in PM pathogenesis is sequestration of IEs in
the placenta. This process may occur through interaction of
VAR2CSA exposed on IE membrane with CSA expressed on
trophoblasts (Fried and Duffy, 1996) or by arrest of IEs in
maternal low blood ﬂow areas (de Moraes et al., 2013). In P.
falciparum infection, VAR2CSA is so far the best characterized
molecule involved in cytoadherence (Salanti et al., 2003, 2004)
and a favored target of PM vaccines (Kane and Taylor-Robinson,
2011). Trophoblasts can respond to infection after IE binding.
In vitro studies with P. falciparum have shown that following IE-
trophoblast interaction placental cells produce chemokines such
as macrophage inﬂammatory protein-1 alpha (MIP-1α/CCL3)
and macrophage migration inhibitory factor (MIF) via activa-
tion of c-Jun N-terminal kinase I (JNK I) which in turn recruit
peripheral blood mononuclear cells to the site (Lucchi et al.,
2008); this inﬂammatory milieu contributes to PM pathology
(Figure 2). Trophoblasts have also been shown to respond to
Plasmodium products such as hemozoin (crystallized heme from
Hb digestion during the blood stage of Plasmodium infection;
Lucchi et al., 2011), P. chabaudi IEs (Poovassery and Moore,
2009), and pathogenic bacteria (Griesinger et al., 2001) releasing
pro-inﬂammatory factors.
Despite VAR2CSA-CSA interactions being exclusive to P.
falciparum-induced PM, the observation that other Plasmod-
ium parasites are capable of causing malaria during pregnancy
both in humans (Poespoprodjo et al., 2008) and mice (Neres
et al., 2008; Rodrigues-Duarte et al., 2012) suggests involve-
ment of other parasite molecules that could target CSA. This
is supported by in vitro data showing that P. berghei IE bind-
ing is CSA-dependent (Neres et al., 2008). The contribution
of VAR2CSA and non-VAR2CSA molecules to PM is cur-
rently being addressed by the characterization of a PM mouse
model induced by transgenic P. berghei parasite that expresses
VAR2CSA molecule (de Moraes et al., unpublished data). Our
recent study of blood circulation patterns in mouse placenta
using intra-vital microscopy showed that IEs and non-IEs are
arrested in regions where maternal circulation is stationary (de
Moraes et al., 2013) suggesting that here P. berghei IE seques-
tration might be independent of molecular interactions with
trophoblasts.
Frontiers in Pharmacology | Drug Metabolism andTransport July 2014 | Volume 5 | Article 155 | 4
Penha-Gonçalves et al. Iron overload in pregnancy malaria
FIGURE 2 | Trophoblast response to IE binding. (A) Cytoadhesion of IE
to trophoblast (TB) via VAR2CSA-CSA interaction leads to chemokine
production by these activated cells (B) and recruitment of inﬂammatory
cells to the site (C). Sequence of events compiled based on studies from
(Fried and Duffy, 1996; Salanti et al., 2004; Lucchi et al., 2008; Srivastava
et al., 2010).
Stationary IEs in low maternal blood spaces can be engulfed
by trophoblasts. Phagocytic activity of trophoblasts occurs in
early stages of pregnancy, during implantation of blastocyst
(Tachi et al., 1970; Bevilacqua and Abrahamsohn, 1989); engulf-
ment of maternal components such as endometrial cells, red
blood cells, and epithelial cells creates space for embryo attach-
ment to the endometrium and its nutrition (Bevilacqua and
Abrahamsohn, 1989). After maturation, trophoblasts seem to
retain their phagocytic activity. Studies have shown that tro-
phoblasts from mid-stage gestation are capable of phagocytos-
ing erythrocytes (Albieri and Bevilacqua, 1996), P. chabaudi
IEs (Poovassery and Moore, 2009), P. berghei parasitic mate-
rial in vitro (Pavia and Niederbuhl, 1991) as well as yeast and
bacteria in vivo (Amarante-Paffaro et al., 2004). Our recent
observation using intra-vital microscopy show that in placen-
tas from gestational day 18, P. berghei IEs are engulfed by
trophoblasts supporting the idea that phagocytic function is
extended until termination of pregnancy (de Moraes et al., 2013;
Figures 1B,C).
DISRUPTION OF INTRACELLULAR HEME HOMEOSTASIS AS A
MECHANISM INVOLVED IN EXCESSIVE IRON ACCUMULATION IN
TROPHOBLAST
In our PM model, abortions, stillbirths, underweight babies, and
maternal mortality are consequences of Plasmodium infection
during pregnancy. These features are associated with irreversible
placental damage, due to IE accumulation. Here we present a
novel hypothesis as to the mechanisms underlying fetal death
in PM. Fetal death/loss during mid-gestation (abortions) has
already been shown to be associated to pro-inﬂammatory cytokine
response to Plasmodium infection in the mouse (Poovassery and
Moore, 2009; Poovassery et al., 2009) and in humans (Okoko
et al., 2003), and to microcirculatory impairments (Avery et al.,
2012). In our model fetal death was observed at end-stage ges-
tation (G19/20): 8/30 fetuses were expelled at G19 and were
very small for gestational age. The remaining fetuses were
assessed in utero, were in general fully developed but under-
weight. Our preliminary data show iron accumulation in tro-
phoblasts in 43% of the infected placentas from dead fetuses
(Table 1), which was associated to the dose/number of Plas-
modium-IEs used in infection of pregnant mice (Figure 3 and
Table 2).
Iron deposits were assessed in placental sections by Perl’s Prus-
sian blue staining (Figure 4). The pattern of excessive iron staining
in placentas from dead fetuses (Figures 4E,F) was observed nei-
ther in non-infected (Figures 4A,B) nor in infected placentas
from live but underweight fetuses (Figures 4C,D); this strongly
Table 1 | Iron accumulation in placentas from live and dead fetuses.
Iron accumulation Live fetuses (n = 20) Dead fetuses (n = 30)
+ 0 13
− 20 17
Association between phenotypes (iron accumulation and death): p < 0.01 (chi-
square test; df = 1).
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FIGURE 3 | Iron accumulation in placenta is dependent on dose of
infection. Pregnant mice were infected with either 104 or 106 Plasmodium
berghei -infected erythrocytes (IEs). Placentas from Plasmodium-infected
pregnant mice were collected at G19/20 and processed for iron
measurements as previously described (Gozzelino et al., 2012). Brieﬂy
placentas were dehydrated overnight, dissolved in 3 M HCl/trichloroacetic
acid (TCA) 10% for 24 h. Labile iron was detected by colorimetric reagent
(bathophenanthroline-disulfonic acid; BPTS) and absorbance was measured
by spectrophotometer (SmartSpec 3000, Bio-Rad); **p < 0.01.
Table 2 | Iron accumulation in placentas from dead fetuses according
to IE dose.
Iron accumulation 106 IEs (n = 15) <106 IEs (n = 14)
+ 13 0
− 2 14
Association between phenotypes (iron accumulation and IE dose): p < 0.01 (chi-
square test; df = 1).
suggests that iron overload in trophoblasts is associated with the
most severe pathological events. Iron was accumulated inside
trophoblasts (Figures 4E,F) and, in particular, at the interface
between trophoblasts and fetal blood capillary and, possibly in
fetal circulation (Figure 4F). Although further experiments would
be required to validate the latter observation, staining was not
observed in maternal blood spaces (Figures 4E–G) supporting
the speciﬁcity of the results obtained. We also observed loss of
placental tissue integrity and cellular damage in regions of iron
positive staining (Figure 4E), which suggests that iron overload
in trophoblasts might induce programmed cell death, presumably
mediated by oxidative stress. Increased apoptosis of trophoblasts
has been linked to adverse pregnancy outcomes such as low birth
weight due to intrauterine growth retardation (IUGR; Endo et al.,
2005), spontaneous abortion (Olivares et al., 2002; Nakashima
et al., 2008), and in a mouse model of intrauterine fetal death
(Mu et al., 2003). In an experimental model of iron overload
during pregnancy, iron accumulation in trophoblasts showed a
ﬁvefold increase but fetal iron content was not modiﬁed, sug-
gesting that transfer of iron across the placenta is, to quote, a
rate-liming step (Martin et al., 2004). Despite these evidences, we
would not rule out the possibility that, in our model, excessive
iron in the placenta is toxic for the fetus; the observation that
iron accumulates at the interface with fetal capillaries and pos-
sibly in the fetal circulation allows us to speculate toward this
direction.
The mechanism proposed to explain iron accumulation in our
model relies on dysregulation of intracellular heme homeostasis
leading to iron overload presumably occurring as a consequence of
increased IE phagocytosis by trophoblasts. These cells are capable
of engulﬁng and digesting red blood cells (Albieri and Bevilac-
qua, 1996) possibly for fetal nutrition at the beginning of gestation
(Bevilacqua andAbrahamsohn, 1989); hence, it is possible that the
mechanisms involved in iron recycling from Hb in the trophoblast
occurs as in macrophages (Bratosin et al., 1998). We would expect
that following phagocytosis, disrupted erythrocytes would lead to
intracellular accumulation of cell-free Hb, a tetramer responsible
for oxygen transport (Bratosin et al., 1998) which upon oxidation
releases its heme prosthetic groups (Schechter, 2008). Non-Hb
bound heme (free heme) sensitizes non-hematopoietic cells to
undergo programmed cell death in response to pro-inﬂammatory
agonists such as tumor necrosis factor (TNF) released in the course
of the infection (Seixas et al., 2009). This deleterious effect is
caused by the iron atom contained within the protoporphyrin
ring of the heme molecule and its ability to produce highly reac-
tive hydroxyl radicals via its participation in the Fenton chemistry
(Gozzelino et al., 2012).
Degradation of heme by the heme catabolizing enzyme heme
oxygenase 1 (HO-1) prevents heme-induced iron cytotoxicity
and generates equimolar amounts of labile iron (Fe2+), car-
bon monoxide (CO), and biliverdin (Tenhunen et al., 1968; Choi
and Alam, 1996; Soares and Bach, 2009; Gozzelino et al., 2010).
Expression of HO-1 is induced in a variety of stress responses,
including to heme itself and is encoded by HMOX1 gene (Ten-
hunen et al., 1968). This is achieved by suppressing the activity
of Bach-1, transcriptional repressor of Hmox-1 gene (Sun et al.,
2002; Gozzelino et al., 2010). The crucial role of HO-1 has already
been demonstrated in cerebral and severe forms of malaria (Pam-
plona et al., 2007; Seixas et al., 2009; Ferreira et al., 2011); increased
expression of this detoxifying enzyme strongly correlates with the
ability to survive the infection. The protection afforded by HO-1
relies on the inhibition of heme sensitization to programmed cell
death.
To limit pro-oxidant effects of iron, a regulatory mechanism
evolved to couple heme catabolism and maintenance of iron
homeostasis. This metabolic iron adaptation is conferred by the
expression of ferritin heavy/heart chain (FtH; Gozzelino and
Soares, 2014). Conversion of Fe2+ into inert Fe3+ is attributed
to the ferroxidase activity of FtH, a property necessary to neu-
tralize the redox activity of labile iron and prevent generation
of oxidative stress (Eisenstein et al., 1991; Harrison and Aro-
sio, 1996). This allows storage of iron inside the multimeric
complex of ferritin, formed by 24 subunits of FtH and fer-
ritin light/liver chain (FtL; Arosio and Levi, 2002) at proportions
that varies between different tissues (Harrison and Arosio, 1996).
The iron storage capacity of the multimeric complex of fer-
ritin can incorporate up to 4500 iron atoms (Harrison and
Arosio, 1996), as inorganic ferrihydrite aggregates from which
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FIGURE 4 | Iron accumulation in trophoblasts. Placentas from
Plasmodium-infected pregnant females were evaluated at G19 for iron
accumulation by Prussian blue staining in placental sections. (A,B)
Non-infected placenta showing maternal blood space (MBS) and fetal
capillary (FC) separated by trophoblast. (C,D) Infected placenta from a live
fetus that shows no iron accumulation in trophoblasts and fairly preserved
tissue structure; (E,F) Infected placenta from a dead fetus showing
signiﬁcant iron accumulation (blue) in trophoblast and loss of integrity of the
tissue structure. Iron seems to be accumulated in phagocytic trophoblasts
(surrounded area in F and box in G) and at the interface between
trophoblast and fetal capillary (arrows in F) but not in MBS (E–G). Areas
delimitated in A,C,E are magniﬁed (crop and zoom) in B,D,F, respectively.
Scale bars: 25 μm (A,C,E) and 10 μm (G). Arrowheads point to infected
erythrocytes.
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are then released according to cellular requirements (Koorts
and Viljoen, 2007). The mechanism of release is currently not
understood.
The cytoprotective effect of FtH relies on its anti-oxidant prop-
erties, which reduce free radicals production (Balla et al., 1992).
Reactive oxygen species (ROS) are responsible for sustained activa-
tion of JNK (Kamata et al., 2005) which induces caspase-3 cleavage
andprogrammed cell death (Gozzelino et al., 2012). Through inhi-
bition of ROS, FtH diminishes JNK phosphorylation (Pham et al.,
2004) preventing cell death. In malaria infection, FtH was shown
to prevent tissue damage and reduces disease severity by providing
a metabolic adaptation to tissue iron overload; this enables mice
and humans to survive to the infection (Gozzelino et al., 2012).
Further experiments would be required in our PM model to assess
the mechanisms by which FtH can protect against trophoblast
damage.
Intracellular accumulation of free heme is also controlled by
the expression of proteins that regulate heme trafﬁcking inside
the cells, known as heme transporters (Yuan et al., 2013). Extra-
cellular release of excessive heme is mediated by the expression
of membrane proteins that act as heme exporters, such as
BCRP/ABCG2 (Krishnamurthy and Schuetz, 2005) and two iso-
forms of the FLVCR1 (Keel et al., 2008; Chiabrando et al., 2012).
FLVCR1a is a cell surface molecule and regulates heme extra-
cellular exit (Keel et al., 2008; Vinchi et al., 2014); FLVCR1b is a
mitochondrial protein that controls heme efﬂux into the cytosol
for hemoglobinization and erythroid differentiation (Chiabrando
et al., 2012).
Our preliminary data also show that FLVCR1a mRNA expres-
sion in infected placentas is downregulated (data not shown)
suggesting that reduced FLVCR1a expression together with intense
trophoblast phagocytic activity may contribute to intracellular
hemeaccumulation (Figure 5). Placentahas been shown to express
high amounts of FLVCR1 (Jaacks et al., 2011) but the functional
roles of thismolecule in this tissue are poorly investigated. FLVCR1
is required for erythroid differentiation maintaining the balance
of intracellular free heme during erythropoiesis (Quigley et al.,
2004) and has an important role in iron recycling by macrophages
(Keel et al., 2008). It has been suggested that expression of FLVCR1
in the placenta may reverse the ﬂow of heme from this tissue to
maternal circulation, so to prevent the fetoplacental unit from
iron toxicity (Cao and O’Brien, 2013). Analysis of FLVCR1 expres-
sion in a population of pregnant adolescents at high risk of
iron deﬁciency showed that FLVCR1 was downregulated in pla-
centas of anemic mothers at term (Jaacks et al., 2011). In our
PM model it is possible that placental FLVCR1a downregula-
tion may be linked to maternal anemia induced by Plasmodium
infection. Engulﬁnghighnumbers of sequestered IEs in lowmater-
nal blood ﬂow regions by trophoblasts expressing low levels of
FLVCR1a could result in heme accumulation. We have not yet
determined if Hb levels and FLVCR1a expression correlates to
IE expansion in the placenta, which could possibly explain iron
overload in placentas from mice infected with higher parasite
numbers.
We could argue thatmechanisms involved in the putative heme-
induced cellular damage observed in infected placentas could
be associated with a decrease in expression of cytoprotective
proteins, such as HO-1 and ferritin. These proteins cooperate
to degrade heme and neutralize the iron released from the pro-
toporphyrin ring of the heme molecule (Gozzelino and Soares,
2014). Whilst HO-1 is responsible for heme catabolism, expres-
sion of ferritin is crucial to neutralize iron generated through
heme degradation and store it inside its multimeric structure
(Gozzelino and Soares, 2014). This would lead to insufﬁcient
function to prevent the damage induced by intracellular heme
accumulation. In fact, administration of anti-oxidant compounds
that mimic the cytoprotective effect of HO-1 prevented heme-
mediated cytotoxicity and pathological outcomes of Plasmodium
infection in mice (Seixas et al., 2009). However, a recent study
in mice with conditional disruption of Flvcr1a gene in the liver
showed that in the absence of FLVCR1a heme and iron accu-
mulated in this organ and that genes such as Ho-1, Fpn, H-Ft
and L-Ft were upregulated suggesting that FLVCR1a is associ-
ated to heme degradation (Vinchi et al., 2014). Therefore it is
possible that in our model heme degradation pathway in tro-
phoblasts is upregulated to compensate for the impaired function
of heme export by FLVCR1a, as previously suggested (Vinchi et al.,
2014).
Heme is synthesized in the mitochondria by a series of
enzymatic reactions and exported to the cytosol to be incor-
porated in hemoproteins (reviewed in Chiabrando et al., 2014).
Mice lacking FLVCR1a in the liver also showed downregula-
tion of genes involved in the heme biosynthesis after injec-
tion of heme precursor 5-aminolevulinic acid (ALA) whereas
in controls treatment induced FLVCR1a upregulation (Vinchi
et al., 2014). Extrapolation of this evidence to our model
allow the speculation that free heme accumulation after
intense phagocytosis of IEs by trophoblast could repress heme
de novo biosynthesis which in turn downregulates FLVCR1a
expression.
Whether there is a role for HO-1 in protection against PM
remains to be established. The notion that this protein is essen-
tial for processes such as oocyte maturation, fertilization, fetus
implantation, and acceptance, Bainbridge and Smith (2005) and
Zenclussen et al. (2007) suggests that the positive potential of
HO-1 in PM is worth to be tested.
FINAL REMARKS
Our PM model represents a severe form of the disease; mecha-
nisms underlying fetal death are still unclear. Our initial obser-
vation that only 43% of placentas from dead fetuses showed
iron accumulation in trophoblasts (Table 1) suggests that iron
overload in PM is a heterogeneous and progressive process and
potentially represents one of the mechanisms to explain fetal
demise. The amount of iron in the placenta was signiﬁcantly
associated with infection dose (Figure 2 and Table 2) implying
that the higher the degree of infection the higher the proba-
bility of iron accumulation. Pregnancy outcomes are improved
when mice are infected with IE doses 100× times lower than
usual; incidence of fetal death is greatly decreased and birth
weight is comparable to normal (unpublished) suggesting that
here infection does not have an important impact on fetal devel-
opment. It could also indicate that lower infection levels may not
deprive the organism of the capacity to activate cytoprotective
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FIGURE 5 | Hypothesis explaining heme-iron overload in trophoblast
according to IE load. Left panel: (A) increased phagocytosis of IEs and
possibly non-IEs by cytotrophoblast (CTB) and syncythiotrophoblasts (STB)
in low blood ﬂow regions in maternal blood space (MBS) where IE and
non-IE are sequestered; (B) disruption of erythrocytes in the phagocytic
vacuole leads to free heme exposure; downregulation of FLVCR1a on
trophoblasts might cause free heme accumulation due to decreased heme
export; (C) heme catabolism by HO-1 generates large amounts of iron
which may exceed ferritin binding capacity; (D) free iron (Fe2+) induces cell
death by ROS. Right panel: (A) lower placental infection might not affect
FLVCR1a expression and phagocytosis is decreased; (B) excessive free
heme is exported from the cell; (C) iron from heme catabolism is
neutralized by ferritin; and (D) trophoblasts are protected from programmed
cell death.
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molecules controlling regulation of heme/iron homeostasis. This
is further supported by the observation that iron accumulation
in infected placentas is associated with the number of injected
IEs.
The main hypothesis we formulate in this article is that
increased phagocytosis of IEs by trophoblasts leads to intracel-
lular iron overload as a consequence of accumulation of free heme
after IE disruption. Based on preliminary evidences we suggest
that infection induces downregulation of FLVCR1a which affects
heme homeostasis triggering cytotoxic events in trophoblasts and
impairing fetal development.
Whether Plasmodium infection induces dysregulation of
molecules involved in heme-iron uptake, storage and/or efﬂux
leading to intracellular iron overload is highly speculative. Never-
theless, our observations that ironwas accumulated at the interface
between trophoblast basalmembrane and fetal capillary encourage
the investigation of FPN expression levels in the infected pla-
centa. We could further elaborate that insufﬁcient function of
FLVCR1a in exporting intracellular heme together with inefﬁcient
iron export through FPN (if shown to be downregulated) might
both contribute to iron accumulation in trophoblasts. Our current
observationswarrant further efforts to investigate ironmetabolism
in PM.
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